On the other hand, knockdown of ERRF in two lapatinib-sensitive ERBB2-positive breast cancer cell lines compromised the effect of lapatinib on cell survival in 2-D and 3-D cultures (Figure 3), further indicating a necessary role of ERRF in breast cancer's sensitivity to lapatinib. The gene discussed is SRARP; the disease is breast cancer.